Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
Bausch Health Shareholders Approve Key Proposals
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
Bausch Health Defends XIFAXAN Patents Amid Litigation
Bausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN Matters
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
RBC Noes Bausch Health Filing For Rehearing in Appellate Court
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
We're exiting a troubled drugmaker and putting the cash into 2 health-care stocks with brighter outlooks
Icahn Enterprises says it will keep paying its $1 quarterly dividend
Morgan Stanley upgrades Bausch + Lomb, cites improving margins
Jim Cramer's top 10 things to watch in the stock market Monday
Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
How previous investing mistakes are shaping my thinking on the latest stock gone wrong
Earnings will drive the market next week — what we expect from 2 portfolio stocks
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.